Open AccessClinical Outcomes and Prevalence of Hepatitis E Virus (HEV) Among Non-A-C Hepatitis Patients in Egypt
Author(s) -
Ibrahim M. Sayed,
Mohamed A. ElMokhtar,
Mahmoud Abdel Rahman Mahmoud,
Amal A. Elkhawaga,
Shereen Gaber,
Nermien H. Seddek,
Lobna Abdel-Wahid,
Ahmed M Ashmawy,
Enas Ahmed Reda Alkareemy
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s289766
Subject(s) - hepatitis e virus , virology , hepatitis e , medicine , genotype , viral hepatitis , ribavirin , virus , biology , hepatitis c virus , gene , biochemistry
Hepatitis E virus (HEV) is an emerging infectious agent that causes acute hepatitis in developing and developed countries. Diagnosis of HEV infection has not been routinely done in Egyptian hospitals, and clinicians do not prescribe ribavirin (RBV) for acute hepatitis cases of unknown etiology (AHUE). We aimed to screen patients with AHUE for the presence of HEV markers and to determine the complications associated with HEV infection.